Weekly doxycycline shows promise for STI prevention in kenyan women on PrEP
NCT ID NCT06582966
First seen Apr 24, 2026 · Last updated Jun 12, 2026 · Updated 5 times
Summary
This study tested whether taking a weekly dose of the antibiotic doxycycline can prevent bacterial sexually transmitted infections (STIs) in cisgender women who are already taking daily PrEP to prevent HIV. The study involved 60 women aged 18-30 in Kisumu, Kenya, and focused on making it easy to stick with the weekly pill routine. The goal was to see if this approach works better than taking doxycycline only after sex, which didn't work well in a previous study because women often forgot to take it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STI are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kenya Medical Research Institute -KEMRI
Kisumu, Kenya
Conditions
Explore the condition pages connected to this study.